Terms: = Prostate cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
414 results:
1. Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
Parajuli KR; Jung Y; Taichman RS
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38624012
[TBL] [Abstract] [Full Text] [Related]
2. Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake.
Dai D; Yu J; Gou W; Yang S; Li Y; Wang Z; Yang Z; Huang T; Li P; Zhu T; Hou W; Zhao Y; Xu W; Li Y
J Med Chem; 2024 Apr; 67(8):6726-6737. PubMed ID: 38570733
[TBL] [Abstract] [Full Text] [Related]
3. Curcumin Enhances the Anti-cancer Efficacy of CDK4/6 Inhibitors in prostate cancer.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Jan; 77(1):57-66. PubMed ID: 38374014
[TBL] [Abstract] [Full Text] [Related]
4. Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
Hardesty JK; Burns RT; Soyster ME; Jansen NE; Mellon M
Urology; 2024 Apr; 186():31-35. PubMed ID: 38369201
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
6. First-in-human study of PSMA-targeting agent, [
Zhao R; Ke M; Lv J; Liu S; Liu Y; Zhang J; Xu L; Gu D; Li M; Cai C; Liu Y; Zeng G; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1753-1762. PubMed ID: 38212531
[TBL] [Abstract] [Full Text] [Related]
7. Resistance to 2-Hydroxy-Flutamide in prostate cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications.
Mora-Rodríguez JM; Sánchez BG; Sebastián-Martín A; Díaz-Yuste A; Sánchez-Chapado M; Palacín AM; Sánchez-Rodríguez C; Bort A; Díaz-Laviada I
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958610
[TBL] [Abstract] [Full Text] [Related]
8. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
9. Aridanin and oleanane-3- O-β-D-glucoside-2'-acetamide obtained from Tetrapleura tetraptera (Schumach. & Thonn) Taub. (Fabaceae) induces potent apoptotic activity in human prostate cancer cells.
Kamdem MHK; Zingue S; Grein T; Maxeiner S; Rutz J; Mmutlane EM; Njamen D; Blaheta RA; Ndinteh DT
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117298. PubMed ID: 37866463
[TBL] [Abstract] [Full Text] [Related]
10. p16 expression in urothelial carcinoma: Experience from a tertiary care center in coastal South India.
Sachdeva S; Suresh PK; Basavaiah SH; Sahu KK; Sreeram S; Kini H; Kini JR; Pinto AC
J Cancer Res Ther; 2023; 19(5):1330-1334. PubMed ID: 37787303
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of Human Papilloma Virus in prostate cancer Patients Undergoing Radical prostatectomy-A Prospective Study of 140 Patients.
Nellessen T; Ebner B; Pyrgidis N; Ledderose S; Kretschmer A; Marcon J; Teupser D; Mayr D; Faihs V; Stief CG; French LE; Herlemann A; Reinholz M
Viruses; 2023 May; 15(6):. PubMed ID: 37376564
[TBL] [Abstract] [Full Text] [Related]
12. PET imaging of new target CDK19 in prostate cancer.
Dai D; Yu J; Huang T; Li Y; Wang Z; Yang S; Li S; Li Y; Gou W; Li D; Hou W; Fan S; Li Y; Zhao Y
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3452-3464. PubMed ID: 37278941
[TBL] [Abstract] [Full Text] [Related]
13. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract] [Full Text] [Related]
14. Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent prostate cancer.
Zamboglou C; Peeken JC; Janbain A; Katsahian S; Strouthos I; Ferentinos K; Farolfi A; Koerber SA; Debus J; Vogel ME; Combs SE; Vrachimis A; Morganti AG; Spohn SKB; Shelan M; Aebersold DM; Grosu AL; Ceci F; Henkenberens C; Kroeze SGC; Guckenberger M; Fanti S; Belka C; Bartenstein P; Hruby G; Scharl S; Wiegel T; Emmett L; Arnoux A; Schmidt-Hegemann NS
JAMA Netw Open; 2023 May; 6(5):e2314748. PubMed ID: 37219907
[TBL] [Abstract] [Full Text] [Related]
15. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.
Ragavi R; Muthukumaran P; Nandagopal S; Ahirwar DK; Tomo S; Misra S; Guerriero G; Shukla KK
Urol Oncol; 2023 Aug; 41(8):340-353. PubMed ID: 37032230
[TBL] [Abstract] [Full Text] [Related]
17. Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced prostate cancer.
Schwarz S; Nientiedt C; Prigge ES; Kaczorowski A; Geisler C; Lucena Porcel C; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2023; 90(5):312-321. PubMed ID: 37004506
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
Elife; 2023 Mar; 12():. PubMed ID: 36883553
[TBL] [Abstract] [Full Text] [Related]
19. The small GTPase arf3 controls invasion modality and metastasis by regulating N-cadherin levels.
Sandilands E; Freckmann EC; Cumming EM; Román-Fernández A; McGarry L; Anand J; Galbraith L; Mason S; Patel R; Nixon C; Cartwright J; Leung HY; Blyth K; Bryant DM
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36880595
[TBL] [Abstract] [Full Text] [Related]
20. Head-to-Head Comparison of 68 Ga-p16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
[Next]